Shaping and realizing our clinical research program and regulatory strategy to obtain regulatory approval and market acceptance of the Trammpolin meniscus prosthesis in the EU and US.
Based in Nijmegen, ATRO Medical is an innovative and ambitious orthopedic startup developing a meniscus prosthesis to relief pain in the large group of meniscus-deficient knee osteoarthritis patients. Since its foundation in 2016, ATRO Medical developed a unique Trammpolin Meniscus Prosthesis, that entered the clinical research stage in 2019 and received FDA Breakthrough device designation in 2020. In the upcoming period our team of 8 excellent professionals will focus on further clinical evidence gathering for market access.
Please send your letter and CV to firstname.lastname@example.org before September 17th. Thank you!